🇺🇸 FDA
Pipeline program

Fimasartan

A657-BR-CT-107

Phase 1 small_molecule completed

Quick answer

Fimasartan for Essential Hypertension is a Phase 1 program (small_molecule) at Yung NA with 1 ClinicalTrials.gov record(s).

Program details

Company
Yung NA
Indication
Essential Hypertension
Phase
Phase 1
Modality
small_molecule
Status
completed

Clinical trials